[Immunomodulatory therapy improves quality of life with rheumatoid arthritis].
Graninger
W
W
Klinische Abteilung für Rheumatologie, Universitätsklinik für Innere Medizin Graz, Auenbruggerplatz 15, 8036 Graz, Osterreich. winfried.graninger@klinikum-graz.at
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000523:psychology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D017060:Patient Satisfaction; D011594:Psychometrics; D011788:Quality of Life / Q000523:psychology*; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D011795:Surveys and Questionnaires
D018501:Antirheumatic Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D008727:Methotrexate
Die immunmodulierende Therapie verbessert die Lebensqualität bei rheumatoider Arthritis.